Fig. 7.
Individual ROC curves for (a) Hex6 HexNAc3 ; (b) Hex5 HexNAc6 Fuc4 ; (c) Hex5 HexNAc5 Fuc2 NeuAc; (d) Hex7 HexNAc6 FucNeuAc2 ; (e) Hex6 HexNAc5 FucNeuAc2 ; (f) Hex6 HexNAc3 Fuc; (g) Hex5 HexNAc5 ; and (h) the combined ROC curve for the optimized seven-glycan composite score, based on their relative abundances in cancer cases vs. controls.